Look for:

Our offer for

ABBOTT LABORATORIES


ISIN:
US0028241000
WKN:
002824100
2022/09/23 17:35:54
Price
102.96 EUR
Difference 0.51% (0.52)

General attributes

ISINUS0028241000
SymbolABT
ExchangeXetra
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)179,200 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)-
Ask (Ask size)-
Open103.82 EUR
High103.82 EUR
Low102.96 EUR
Close (prev. day)102.44 EUR
VWAP103.29833 EUR
Volume (pcs)48
Trading volume4,958.32
Number of trades5
Last size-

Futures and Options

Related Futures15
Related Options-

PDF Downloads

Annual report: ABBOTT LABORATORIESPDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2022/09/23 17:35:54
Price
102.96 EUR
Difference 0.51% (0.52)

General attributes

ISINUS0028241000
SymbolABT
ExchangeXetra
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)179,200 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)-
Ask (Ask size)-
Open103.82 EUR
High103.82 EUR
Low102.96 EUR
Close (prev. day)102.44 EUR
VWAP103.29833 EUR
Volume (pcs)48
Trading volume4,958.32
Number of trades5
Last size-

Performance and Risk

6M1Y3Y
Perf (%)-4.22%-3.69%+35.37%
Perf (abs.)-4.54-3.94+26.90
Beta0.830.800.81
Volatility23.2123.4227.41
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)102.93 EUR (209)
Ø price 30 days | Ø volume 30 days (pcs.)105.50 EUR (442)
Ø price 100 days | Ø volume 100 days (pcs.)105.55 EUR (717)
Ø price 250 days | Ø volume 250 days (pcs.)108.87 EUR (878)
YTD High | date125.00 EUR (2022/01/03)
YTD Low | date96.32 EUR (2022/06/17)
52 Weeks High | date126.55 EUR (2021/12/30)
52 Weeks Low | date96.32 EUR (2022/06/17)

All listings for ABBOTT LABORATORIES

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2022/09/2317:35102.96 EUR0.005
Vienna Stock Exchange2022/09/2317:32102.88 EUR0.002
Tradegate2022/09/2322:26103.97 EUR0.2637
Stuttgart2022/09/2321:24103.04 EUR0.007
SIX Swiss Exchange2022/09/1417:30106.00 CHF0.001
NYSE2022/09/2322:03100.68 USD622.0575,975
Munich2022/09/2308:00102.52 EUR0.001
London Stock Exchange2022/09/2315:30100.39 USD13.173
Hanover2022/09/2308:01102.46 EUR0.001
Hamburg2022/09/2308:01102.46 EUR0.001
Frankfurt2022/09/2309:15102.72 EUR0.012
Duesseldorf2022/09/2321:02102.64 EUR0.0011
Berlin2022/09/2321:52103.84 EUR0.0018

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=2546&ID_TYPE_IMAGE_LOGO=2

Contact Details

ABBOTT LABORATORIES
- -
100 Abbott Park Road - 60064-6400 Abbott Park
Telefon: 1-224-667-6100
Fax: -
E-mail: -

PDF Downloads

Annual report: ABBOTT LABORATORIESPDF Download

Company Profile

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1900 and is headquartered in Abbott Park, IL.

Members of Management Board

Robert AlpernMember of Board of Directors
Sally BlountMember of Board of Directors
Claire Babineaux-FontenotMember of Board of Directors
Daniel StarksMember of Board of Directors
Darren McDewMember of Board of Directors
Glenn TiltonMember of Board of Directors
John StrattonMember of Board of Directors
Michael RomanMember of Board of Directors
Michelle KumbierMember of Board of Directors
Nancy McKinstryMember of Board of Directors
Paola GonzalezMember of Board of Directors
William OsbornMember of Board of Directors
Robert B. FordChairman of Managing Board
John M. CapekMember of Executive Committee
Alejandro WellischMember of Executive Committee
Andrea F. WainerMember of Executive Committee
Andrew H. LaneMember of Executive Committee
Christopher J. CalamariMember of Executive Committee
Daniel SalvadoriMember of Executive Committee
Greg AhlbergMember of Executive Committee






Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. For more details please read our Data protection policy.

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended). For this reason, the distribution or redistribution of the information, materials and products into United States or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited. The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.